CS logo
small CS logo
Smilow Cancer Hospital Care Center at North Haven

North Haven, Connecticut, United States
Cancer treatment center in North Haven, Connecticut
6 Devine St, North Haven, CT 06473

About Smilow Cancer Hospital Care Center at North Haven


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Smilow Cancer Hospital Care Center at North Haven


During the past decade, Smilow Cancer Hospital Care Center at North Haven conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Smilow Cancer Hospital Care Center at North Haven" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator, "Pierre Fabre Medicament" with 1 trials as a collaborator and "Westat" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

Clinical Trials Conditions at Smilow Cancer Hospital Care Center at North Haven


According to Clinical.Site data, the most researched conditions in "Smilow Cancer Hospital Care Center at North Haven" are "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Colorectal Cancer Metastatic" (1 trials), "Light Chain (AL) Amyloidosis" (1 trials) and "Non-small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Smilow Cancer Hospital Care Center at North Haven" in a lesser frequency.

Clinical Trials Intervention Types at Smilow Cancer Hospital Care Center at North Haven


Most popular intervention types in "Smilow Cancer Hospital Care Center at North Haven" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab" (2 trials), "durvalumab" (2 trials), "5-Fluorouracil" (1 trials), "BYL719" (1 trials) and "Binimetinib" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Smilow Cancer Hospital Care Center at North Haven


The vast majority of trials in "Smilow Cancer Hospital Care Center at North Haven" are 6 trials for "All" genders.

Clinical Trials Status at Smilow Cancer Hospital Care Center at North Haven


Currently, there are NaN active trials in "Smilow Cancer Hospital Care Center at North Haven". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Smilow Cancer Hospital Care Center at North Haven, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Smilow Cancer Hospital Care Center at North Haven, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".